Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acacia Pharma
Acacia Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Barhemsys
Amisulpride
2020-02-26
2031-2038
—
Byfavo
Remimazolam
2020-10-06
2027-2033
Conscious sedation
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Amisulpride
healthy volunteers/patients
,
chronic kidney failure
,
postoperative nausea and vomiting
,
vomiting
,
nausea
Enoblituzumab
diabetes mellitus
,
wound infection
,
healthy volunteers/patients
,
infections
,
chronic renal insufficiency
,
kidney diseases
,
ovarian neoplasms
,
prostatic neoplasms
,
carcinoma
,
colorectal neoplasms
,
breast neoplasms
,
pancreatic neoplasms
,
neoplasms
,
stomach neoplasms
,
head and neck neoplasms
,
thyroid neoplasms
,
esophageal neoplasms
,
lung neoplasms
,
sarcoma
,
uterine neoplasms
,
melanoma
,
kidney neoplasms
,
colonic neoplasms
,
fallopian tube neoplasms
,
adenocarcinoma
,
pneumococcal infections
Calcium dobesilate
plasma cell neoplasms
,
breast neoplasms
,
neoplasm metastasis
,
malignant mesothelioma
,
mesothelioma
,
lymphoid leukemia
,
lymphoma
,
non-hodgkin lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
t-cell leukemia
,
b-cell leukemia
,
prostatic neoplasms
,
mantle-cell lymphoma
,
multiple myeloma
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
macular edema
,
vision disorders
,
myeloid leukemia acute
,
congenital abnormalities
,
megakaryoblastic leukemia acute
,
monocytic leukemia acute
,
myelomonocytic leukemia acute
,
basophilic leukemia acute
,
erythroblastic leukemia acute
,
eosinophilic leukemia acute
,
retinal vein occlusion
Lornoxicam
b-cell lymphoma
,
inflammatory breast neoplasms
,
immunoglobulin light-chain amyloidosis
,
myeloproliferative disorders
,
primary myelofibrosis
,
promyelocytic leukemia acute
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia acute
,
myelomonocytic leukemia juvenile
,
acute disease
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
large b-cell lymphoma diffuse
,
leukemia
,
myeloid leukemia acute
,
precursor cell lymphoblastic leukemia-lymphoma
,
non-hodgkin lymphoma
,
lymphoid leukemia
,
lymphoma
,
myeloid leukemia
,
myelodysplastic syndromes
,
multiple myeloma
,
plasma cell neoplasms
,
bcr-abl positive chronic myelogenous leukemia
,
preleukemia
,
neoplasms
,
b-cell chronic lymphocytic leukemia
,
triple negative breast neoplasms
,
refractory anemia with excess of blasts
,
renal insufficiency
,
hematologic diseases
,
blood protein disorders
,
neoplasms by histologic type
,
paraproteinemias
,
hodgkin disease
,
diabetes mellitus
,
type 1 diabetes mellitus
,
prolymphocytic leukemia t-cell
,
prolymphocytic leukemia
,
recurrence
,
burkitt lymphoma
,
graft vs host disease
,
bronchiolitis obliterans syndrome
,
aplastic anemia
,
breast neoplasms
,
brain stem neoplasms
,
glycogen storage disease type ii
,
glycogen storage disease type iii
,
ovarian neoplasms
,
hematologic neoplasms
Bos taurus adrenal cortex corticosteroids
multiple myeloma
,
plasma cell neoplasms
,
leukemia
,
lymphoid leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
crohn disease
,
ulcerative colitis
,
colitis
,
ulcer
,
hereditary angioedemas
Anthracycline
neoplasms
,
hodgkin disease
,
myeloid leukemia acute
,
breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
neutropenia
,
chemotherapy-induced febrile neutropenia
,
non-hodgkin lymphoma
,
lymphoma
,
mantle-cell lymphoma
,
promyelocytic leukemia acute
APD209
wasting syndrome
,
cachexia
Trinessa
chronic renal insufficiency
,
renal insufficiency
,
anemia
,
healthy volunteers/patients
Fluoroquinolone
healthy volunteers/patients
,
neoplasms
Isoxaflutole
hypogonadism
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use